| 标题 |
337MO Efficacy and safety of rezvilutamide (Rez) plus androgen-deprivation therapy (ADT) in patients with high-volume, metastatic, hormone-sensitive prostate cancer (mHSPC) aged ≤64, 65–74, and ≥75 years: Post-hoc analysis of randomized phase III CHART trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:D. Ye; X. Bian; S. Jiang; H. Luo; F. Zhou; et al 出版日期:2024-12-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)